2024-03-28T15:44:59Z
https://niigata-u.repo.nii.ac.jp/oai
oai:niigata-u.repo.nii.ac.jp:00023493
2022-12-15T03:53:43Z
453:456
471:537:538:1222
2) 胃・十二指腸潰瘍の薬物療法(シンポジウム 食道・胃・十二指腸潰瘍の薬物療法, 第416回新潟医学会)
2) 胃・十二指腸潰瘍の薬物療法(シンポジウム 食道・胃・十二指腸潰瘍の薬物療法, 第416回新潟医学会)
Drug Therapy of Gastric and Duodenal Ulcers(Current Medical Therapy for Upper Gastrointestinal Ulcer Disease)
杉山, 一教
富所, 隆
Therapeutic Drugs of ulcer
H_2-receptor antagonist
Recurrence
Defensive factor
Maintenance therapy
潰瘍の治療薬
H_2-blocker
再発
防御因子
維持療法
Therapy of gastric and duodenal ulcers has achieved a striking progress of the appearance of muscarin receptor antagonist (pirenzepine) and histamine H_2-receptor antagonist (H_2-blocker). Especially disappearance of subjective symptoms and promotion of cure achieved by these drugs are widely well-appreciated. On the other hand, with the acumulation of use experience of the drugs, much attention is being paid to the importance of early recurrence and maintenance therapy. At this point, attention is newly focused on the reevaluation of conventional enhancers of defensive factors. The authors describe the current status of therapy of peptic ulcers mainly based on our experience.
新潟医学会
1988-05
jpn
departmental bulletin paper
http://hdl.handle.net/10191/40764
https://niigata-u.repo.nii.ac.jp/records/23493
AN00182415
00290440
新潟医学会雑誌
新潟医学会雑誌
102
5
249
255
https://niigata-u.repo.nii.ac.jp/record/23493/files/102(5)_249-255.pdf
application/pdf
1.3 MB
2019-08-19